Comparison of Continuous and Programmed Intermittent Bolus Infusion of 0.2% Ropivacaine after Ultrasound-Guided Continuous Interscalene Brachial Plexus Block in Arthroscopic Shoulder Surgery.

Authors:
Kim HJ; Baek JH; Park S; Yoon JU; Byeon GJ and 1 more

Journal:
Pain Res Manag

Publication Year: 2022

DOI:
10.1155/2022/2010224

PMCID:
PMC9807309

PMID:
36601435

Journal Information

Full Title: Pain Res Manag

Abbreviation: Pain Res Manag

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Psychophysiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"This work was supported by a 2-year research grant of Pusan National University."

Evidence found in paper:

"This study was approved by the Institutional Review Board of Pusan National University Yangsan Hospital (approval number: 05–2020-089), and the trial was registered with the Clinical Research Information Service (registration number: KCT0005197). After obtaining written informed consent, 64 patients aged >19 years with American Society of Anesthesiologists physical status I–II scheduled for elective arthroscopic shoulder surgery were enrolled. Patients who did not understand or could not participate in the study process, had a blood coagulation deficiency, neurological defects at the procedure site, allergic reaction to ropivacaine in previous surgery or procedures, or were pregnant women were excluded."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025